# OnCo record catenabio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/catenabio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "catenabio" ;
  schema:name "CatenaBio"@en ;
  schema:alternateName "Catena Biosciences"@en, "Catena Biosciences, Inc."@en ;
  schema:description "CatenaBio is a California company that joins two different cancer-killing drugs onto one antibody, so a single medicine can attack a tumour in two ways. Its lead medicine, CATB-101, targets TROP2 and is in laboratory and animal testing."@en ;
  schema:url <https://onco.cc/companies/catenabio/>, <https://catenabio.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://catenabio.com/>, <https://catenabio.com/pipeline/>, <https://reporter.nih.gov/project-details/11408201> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/catb-101/> .